Takeda announces fy2024 full year results and fy2025 outlook reflecting growth & launch products momentum, strong cash flow generation and late-stage pipeline progress

Osaka, japan--(business wire)--takeda (tokyo:4502/nyse:tak) today announced financial results for fiscal year 2024 (period ended march 31, 2025) with continued strong momentum in growth & launch products offsetting loss of exclusivity impact to drive revenue and core operating profit growth, supported by robust cost management. takeda has built a high-value late-stage pipeline with potentially life-transforming new treatment options for patients. following a positive phase 3 readout for rus.
TAK Ratings Summary
TAK Quant Ranking